OPB-51602: a novel STAT3 inhibitor that targets mitochondrial respiratory chain and triggers STAT3 dependent ROS production

被引：2
|
作者：
Hirpara, Jayshree L.
Higuchi, Kumi
Tsunoda, Takeshi
Goh, Boon Cher
Pervaiz, Shazib
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3080
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3080
引用
收藏
页数：3
相关论文
共 50 条
  • [1] STAT3 Inhibitor OPB-51602 Is Cytotoxic to Tumor Cells Through Inhibition of Complex I and ROS Induction
    Brambilla, Lara
    Lahiri, Tanaya
    Cammer, Michael
    Levy, David E.
    ISCIENCE, 2020, 23 (12)
  • [2] PHASE I STUDY OF OPB-51602, AN INHIBITOR OF STAT3 PHOSPHORYLATION, IN PATIENTS WITH RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
    Terui, Y.
    Ogura, M.
    Uchida, T.
    Hayakawa, F.
    Kobayashi, Y.
    Taniwaki, M.
    Takamatsu, Y.
    Naoe, T.
    Tobinai, K.
    Munakata, W.
    Kitamura, K.
    Usui, N.
    Komatsu, N.
    Yamauchi, T.
    Kageyama, A.
    Hatake, K.
    HAEMATOLOGICA, 2014, 99 : 35 - 35
  • [3] Novel STAT3 inhibitors targeting the STAT3 dimerization
    Hua, Yaping
    Azeem, Waqas
    Oyan, Anne Margrete
    Kalland, Karl-Henning
    CANCER RESEARCH, 2022, 82 (12)
  • [4] A Novel Inhibitor of STAT3 Homodimerization Selectively Suppresses STAT3 Activity and Malignant Transformation
    Zhang, Xiaolei
    Sun, Ying
    Pireddu, Roberta
    Yang, Hua
    Urlam, Murali K.
    Lawrence, Harshani R.
    Guida, Wayne C.
    Lawrence, Nicholas J.
    Sebti, Said M.
    CANCER RESEARCH, 2013, 73 (06) : 1922 - 1933
  • [5] Phase I study of OPB51602, a small molecule inhibitor of STAT3 phosphorylation, in patients with refractory solid malignancies
    Goh, Boon C.
    Wong, Andrea L. A.
    Soo, Ross A.
    Kong, Li-Ren
    Zee, Ying Kiat
    Chuah, Benjamin
    Lee, Soo-Chin
    Mikami, Tomomi
    Yuasa, Miyuki
    Marban, Patrick
    Yong, Wei-Peng
    Lwin, Thuya Win
    Zhu, Qian
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies
    Wong, A. L.
    Soo, R. A.
    Tan, D. S.
    Lee, S. C.
    Lim, J. S.
    Marban, P. C.
    Kong, L. R.
    Lee, Y. J.
    Wang, L. Z.
    Thuya, W. L.
    Soong, R.
    Yee, M. Q.
    Chin, T. M.
    Cordero, M. T.
    Asuncion, B. R.
    Pang, B.
    Pervaiz, S.
    Hirpara, J. L.
    Sinha, A.
    Xu, W. W.
    Yuasa, M.
    Tsunoda, T.
    Motoyama, M.
    Yamauchi, T.
    Goh, B. C.
    ANNALS OF ONCOLOGY, 2015, 26 (05) : 998 - 1005
  • [7] Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain
    Hua, Yaping
    Yuan, Xing
    Shen, Yun-heng
    Wang, Jinxin
    Azeem, Waqas
    Yang, Shuo
    Gade, Alexandra
    Lellahi, Seyed Mohammad
    oyan, Anne Margrete
    Ke, Xisong
    Zhang, Wei-dong
    Kalland, Karl-Henning
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Extended cohort study of OPB51602, a novel inhibitor of STAT3/5 activation, in non-small cell lung carcinoma.
    Lim, Joline Si Jing
    Wong, Andrea Li Ann
    Soo, Ross A.
    Lee, Soo-Chin
    Marban, Patrick
    Kong, Li Ren
    Pang, Brendan
    Soong, Richie Chuan Teck
    Tan, Daniel Shao-Weng
    Tan, David Shao Peng
    Higuchi, Kumi
    Motoyama, Masaaki
    Tsunoda, Takeshi
    Goh, Boon C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] STAT3 inhibition induced temozolomide-resistant glioblastoma apoptosis via triggering mitochondrial STAT3 translocation and respiratory chain dysfunction
    Cui, Ping
    Wei, Fen
    Hou, Jingjing
    Su, Ying
    Wang, Jijun
    Wang, Sicen
    CELLULAR SIGNALLING, 2020, 71
  • [10] Induction of mitochondrial reactive oxygen species by a novel STAT3 inhibitor triggers apoptosis in human glioblastoma cells
    Fraga, Magdalena
    Mackenzie, Gerardo Guillermo
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 108 : S84 - S84
12345